Patient-focused drug discovery

2cureX is a drug discovery company that rapidly generates drug candidates for the treatment of cancer in defined subpopulations of patients

2cureX’s ChemoCellomics™ technology integrates

• synthesis of "high-value" chemical libraries and high throughput screening (HTS) directly in primary cells from patients

• functional profiling of cancer patients with development of novel drug candidates

2cureX is developing its drug candidates, together with hospital partners, until proof of principle in man has been shown. Subsequent product development will be driven by partnerships with established pharmaceutical or biotechnology companies.